The scientists Cécile und Oskar Vogt, between them N. W. Timoféeff-Ressovsky
Medical-biological research has a 75-year tradition at Berlin-Buch. Here in 1930 the Institute for Brain Research of the Kaiser Wilhelm Association with the affiliated neurological clinic was established, with Oskar Vogt as director. At that time the institute was the largest and most modern of its kind in the world. Vogt's work focused on histological-anatomic and functional layer- and field structures (topistic) of the cerebral cortex. From 1937 on, Vogt's successor directed the institute's research onto various neuropathological problems including brain tumors. The institute achieved special renown through the work of the Russian geneticist N. W. Timoféeff-Ressovsky on gene mutations and the structure of the gene, in part together with Max Delbrück.
At Work: the geneticist Timoféeff-Ressovsky
In 1947 the institute and clinic were combined as the Institute for Medicine and Biology and placed under the auspices of the German Academy of Sciences in Berlin. The institute became a well-known center for cancer research with research projects on the chemical genesis of cancer, oncogenic viruses, biochemistry, immunology, genetics and radiobiology as well as the clinical treatment of tumors. From 1956 onward, a second emphasis was placed on cardiovascular research, likewise integrating research and clinical practice. In 1972 the different Academy research institutes at Buch merged to form the central institutes for molecular biology, for cancer research and for cardiovascular research.
The former Robert Rössle Hospital, the so-called Tumor Clinic
With the unification of West and East Germany in 1990, the academy institutes were phased out in accordance with the unification agreement. Subsequently, the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch was founded on the Campus in 1992. Starting in 1995, biotechnology companies have settled on the Campus in the Innovation and Founding Center. In 2000 the Leibniz Institute for Molecular Pharmacology (FMP) was established.
Since 2011 the Experimental and Clinical Research Center (ECRC) has been housed in the Robert Rössle Building of the former Tumor Clinic. The ECRC is a joint institution of the Berlin Charité and the Max Delbrück Center with research departments and outpatient clinics of different medical departments.
Building of the Institute for Brain Research of the Kaiser Wilhelm Society, now named after the founders Cécile and Oskar Vogt
News Buch Berlin
Phage capsid against influenza: perfectly fitting inhibitor prevents viral infection
A new approach brings the hope of new therapeutic options for suppressing seasonal influenza and avian flu: On the basis of an empty – and therefore non-infectious – shell of a phage virus, researcher...more ...
Millions for cancer research
Thomas Blankenstein receives an ERC Advanced grant for cancer research. The scientist from the MDC wants to find out if T cells control the development of cancer by a process called immunosurveillance...more ...
Understanding the Formation of Nerve Cell Contacts - Volker Haucke receives 2.5 Million Euros of Funding from the European Research Council (ERC)
Professor Volker Haucke from the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) and the Freie Universität Berlin receives a prestigious ERC Advanced Grant of the European Research Counc...more ...
Events Buch Berlin
ENTFÄLLT: Die Lange Nacht der Wissenschaften: Die klügste Nacht des Jahres
Epigenetik und die große Frage: Beeinflusst die Umwelt unser Erbgut?
Die Epigenetik bietet konzeptionell neue Ansätze für das Verständnis genetischer Regulation von Entwicklungs- und Erkrankungs-Prozessen. Epigenetische Modifikationen spielen in Pflanzen, im Tier und i...more ...